Production (Stage)
MEI Pharma, Inc.
MEIP
$2.18
$0.03081.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -221.06% | -292.59% | -213.22% | 155.84% | 169.06% |
| Total Depreciation and Amortization | 38.48% | 57.77% | 77.54% | -0.78% | -4.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 229.47% | 198.89% | 288.57% | 299.54% | -13.16% |
| Change in Net Operating Assets | 76.55% | 85.08% | 87.71% | -237.82% | -215.74% |
| Cash from Operations | 16.89% | 31.97% | 22.71% | 3.83% | 22.77% |
| Capital Expenditure | 100.00% | 100.00% | -125.00% | 80.00% | 86.27% |
| Sale of Property, Plant, and Equipment | 8,600.00% | 176.92% | -- | -- | -200.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 10.49% | -7.03% | 31.18% | -8.52% | -10.36% |
| Cash from Investing | 11.64% | -6.93% | 31.10% | -8.47% | -9.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 98.22% | 98.22% | -- | -- | -58,400.00% |
| Cash from Financing | 98.22% | 98.22% | -- | -29,570.00% | -58,200.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 380.94% | 423.26% | 131.73% | -1,232.16% | -180.17% |